Prostarm Info Systems Submits Revised Monitoring Agency Report for Q4 FY2025-26 Under SEBI Regulation 32
Prostarm Info Systems Limited submitted a revised Monitoring Agency Report for Q4 FY2025-26, covering IPO proceeds of INR 168.000 Cr. raised during May 27–29, 2025. As at March 31, 2026, INR 155.517 Cr. had been utilized across working capital, debt repayment, general corporate purposes, and issue expenses, with INR 12.483 Cr. remaining unutilized against the inorganic growth object. The unutilized funds are currently held in fixed deposits with ICICI Bank, earning a total of INR 0.025 Cr. The Monitoring Agency, Acuité Ratings and Research Limited, confirmed no material deviation from the objects of the issue, while noting a 43-day delay in the inorganic growth objective. The company has proposed redeployment of the unutilized funds towards working capital requirements, subject to shareholder approval.

*this image is generated using AI for illustrative purposes only.
Prostarm Info Systems Limited has filed a revised Monitoring Agency Report for the quarter ended March 31, 2026 (Q4 FY2025-26), pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 41(4) of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The report was prepared by Acuité Ratings and Research Limited, the appointed Monitoring Agency, to oversee the utilization of proceeds from the company's Initial Public Offering. The company clarified that the revised submission was necessitated by the inadvertent attachment of an unsigned copy in the earlier intimation, and that the contents of the report remain unchanged.
IPO Issue Overview
The company, which operates in the Other Electrical Equipment / Capital Goods sector, conducted its public issue during May 27, 2025 to May 29, 2025. The key details of the issue are summarized below:
| Parameter: | Details |
|---|---|
| Issue Period: | May 27, 2025 to May 29, 2025 |
| Type of Issue: | Public Issue |
| Type of Securities: | Equity Shares |
| Issue Size: | INR 168.000 Cr. |
| Monitoring Agency: | Acuité Ratings and Research Limited |
Utilization of IPO Proceeds
The Monitoring Agency reviewed the deployment of IPO proceeds across all stated objects as at the end of Q4 FY2025-26. The report indicates that the majority of funds have been fully utilized, with one object remaining pending. The following table captures the progress in utilization:
| Item Head: | Amount Proposed [INR Cr.] | Amount Raised [INR Cr.] | Utilized at End of Quarter [INR Cr.] | Unutilized [INR Cr.] |
|---|---|---|---|---|
| Funding working capital requirements: | 72.500 | 72.500 | 72.500 | Nil |
| Prepayment/repayment of outstanding borrowings: | 17.958 | 17.958 | 17.958 | Nil |
| Inorganic growth through unidentified acquisitions & strategic initiatives: | 12.483 | 12.483 | - | 12.483 |
| General Corporate Purposes: | 42.000 | 42.000 | 42.000 | Nil |
| Issue Expense: | 23.059 | 23.059 | 23.059 | Nil |
| Total: | 168.000 | 168.000 | 155.517 | 12.483 |
General Corporate Purpose Utilization
The INR 42.000 Cr. allocated under General Corporate Purposes was fully utilized by the end of the quarter. The breakdown of its deployment is as follows:
| Item Head: | Amount [INR Cr.] |
|---|---|
| For Working Capital: | 28.81 |
| For Capacity Expansion: | 13.19 |
| Total: | 42.000 |
The Monitoring Agency confirmed that the company had fully utilized the funds allocated towards these objects.
Delay in Inorganic Growth Object and Deployment of Unutilized Funds
A delay of 43 days (as on the Monitoring Agency report date) was noted in the implementation of the inorganic growth object, which had a completion date of March 31, 2026, as per the offer document. The object is yet to start. The Board of Directors stated that despite a detailed evaluation of domestic and international acquisition opportunities, no opportunity was identified that met the company's desired strategic and financial parameters, resulting in the temporary non-utilization of these funds.
The INR 12.483 Cr. in unutilized proceeds has been deployed in fixed deposits, as detailed below:
| Instrument & Account: | Amount Invested [INR Cr.] | Maturity Date | Earning [INR Cr.] | Return on Investment (%) | Market Value at End of Quarter [INR Cr.] |
|---|---|---|---|---|---|
| Fixed Deposit – ICICI Bank (280213015400): | 5.403 | 09-12-2026 | 0.011 | 6.25 | 5.51 |
| Fixed Deposit – ICICI Bank (280213015399): | 6.000 | 09-12-2026 | 0.012 | 6.25 | 6.12 |
| Fixed Deposit – ICICI Bank (280213015413): | 1.080 | 11-06-2027 | 0.002 | 6.40 | 1.10 |
| Total: | 12.483 | 0.025 | 12.73 |
The company's management has proposed redeployment of the unutilized IPO proceeds towards funding working capital requirements and is in the process of seeking requisite shareholder approval for the same. The Board noted that any future inorganic growth or strategic opportunities will be considered for funding through internal accruals or other permissible sources.
Monitoring Agency Findings
The Monitoring Agency, Acuité Ratings and Research Limited, confirmed that no material deviation from the objects of the issue was observed, and no change in the means of finance was noted. Key findings from the compliance review are summarized below:
- Deviation from objects: No deviation observed
- Material deviation requiring shareholder approval: Not applicable
- Change in means of finance: No change observed
- Favorable/unfavorable events affecting viability: None observed
- Government/statutory approvals: Not required for the stated objects
- Information materially affecting investor decision-making: None evident
The report was signed by Vikas Mishra, Deputy Vice President – Process Excellence, Acuité Ratings and Research Limited, and submitted on behalf of Prostarm Info Systems by Sachin Gupta, Company Secretary and Compliance Officer (Membership No: F12500).
Historical Stock Returns for Prostarm Info Systems
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.99% | -7.36% | +0.05% | -10.04% | +15.21% | +15.21% |
Will Prostarm Info Systems successfully secure shareholder approval to redeploy the INR 12.483 Cr. towards working capital, and what timeline is expected for this resolution?
Given the 43-day delay in identifying suitable acquisition targets, how might Prostarm's inorganic growth strategy evolve, and could the company revisit this objective in future fundraising plans?
How will the full utilization of INR 72.500 Cr. towards working capital requirements impact Prostarm's revenue growth and operational capacity in FY2026-27?


































